Skip to main content

RXQ Compounding LLC

No ongoing recalls currently shown

Based on the official records currently available to Public Health Trace, no recalls naming RXQ Compounding LLC are currently shown as ongoing. The 88 records below are historical recall records.

Public Health Trace has 88 recalls naming RXQ Compounding LLC as the recalling firm, republished from official FDA and USDA sources.

Recall history - 88 terminated records

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20171
20181
201986
Download CSV

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

VITAMIN B COMPLEX 100 (PFV), [2 or 30 ML] per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 2 ML Vial: 70731-0961-02; NDC 30 ML Vial: 70731-0961-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

STERILE WATER FOR INJECTION USP, [10, 30, or 50 ML] per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 10 ML vial: 70731-0188-10; NDC 30 ML vial: 70731-0188-30; NDC 50 ML vial: 70731-0188-50

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

LIDOCAINE 0.75%/Epinephrine 0.025%/BSS 0.56ML SYR, 1 ML PER Syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0919-01

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

RXQ CAIN (PHENYLEP 1.5%/ LIDO 1% OPHTH SOL (PF), 1 ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0918-01

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

ROPIVICAINE 0.2%, INJ SOLN, 550 ML ON-Q PUMP. RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0238-55

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

PROCAINE HCL 20 MG/ML (MDV) INJECTABLE SOLUTION, 30 ML per vial. RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0987-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

PREDNISOLONE 1%, MOXIFLOXACIN 0.5% OPHTH SOL, 5ML per dropper bottle, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0109-05

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

POTASSIUM CHLORIDE 15% (2MEQ/ML) INJ SOLN, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0954-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

PHENYLEPHRINE HCL 100 MCG/ML IN NACL 0.9% SYR, 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0136-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

ONDANSETRON 2 MG/ML INJECTION SOLUTION (NPF), 20ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0157-20

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

NIACINAMIDE 100MG/ML, 10ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0938-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: September 16, 2022Historical recordClass II

NEOSTIGMINE METHYL SULFATE 1MG/ML INJ SOL SYR, 5 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0143-05

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Published
August 14, 2019
Distribution
Nationwide

View recall →

Some FDA recall records on this page come from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.

This page lists recalls that name RXQ Compounding LLC as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.